Medications
FDA approves Nemluvio for prurigo nodularis
The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.
Aug 16, 2024
0
0
The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.
Aug 16, 2024
0
0